The LRRK2 Cohort Consortium, funded by the Michael J. Fox Foundation, brought research groups together to speed efforts to move LRRK2 toward therapeutic relevance for patients. The CTSDMC served as the Statistical Core for this project.
Read more about LRRK2 Cohort Consortium on the MJFF website.